| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-06 | 2009-09-30 | 13F-HR | Credit Suisse First Boston | Institution | | Sold All | -29,192 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 21,669 | No Change | 0 | 0 % | $83,426 | $83,426 | $0 | 0.00 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 50 | Sold Some | -2,884 | -98.29 % | $193 | $193 | $0 | 0.00 % | $0 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tcw Group Inc | Institution | 198,375 | Sold Some | -64,673 | -24.58 % | $763,744 | $763,744 | $0 | 0.00 % | $0 | | | | | | News Article | History of Tcw Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 27,136 | No Change | 0 | 0 % | $104,474 | $104,474 | $0 | 0.00 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 181,833 | Sold Some | -7,300 | -3.85 % | $700,057 | $700,057 | $0 | 0.00 % | $0 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | | Sold All | -10,411 | -100 % | | | | -0.77 % | $312 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ga Funds-Ssga Enhanced Small Cap Fund | Small-Cap Core | | Sold All | -600 | -100 % | | | | 1.04 % | $-24 | | | | | | News Article | History of Ga Funds-Ssga Enhanced Small Cap Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 54,300 | New Holding | 54,300 | 100 % | $214,485 | $209,055 | $-5,430 | -2.53 % | $-5,430 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios-Technology Portfolio | Science & Tech | 102,400 | No Change | 0 | 0 % | $404,480 | $394,240 | $-10,240 | -2.53 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios-Technology Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 20,245 | Added More | 4,295 | 26.92 % | $84,827 | $77,943 | $-6,883 | -8.11 % | $-1,460 | | | | | | News Article | History of Oxford Asset Management Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 1,275 | No Compare | | | $5,342 | $4,909 | $-434 | -8.11 % | | | | | | | News Article | History of Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 656,507 | Sold Some | -500 | -0.07 % | $2,960,847 | $2,527,552 | $-433,295 | -14.63 % | $330 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust-Cornerstone Strategy Fund | Specialty & Misc | 2,100 | New Holding | 2,100 | 100 % | $9,471 | $8,085 | $-1,386 | -14.63 % | $-1,386 | | | | | | News Article | History of Usaa Mutual Funds Trust-Cornerstone Strategy Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I-Small Cap Index Fund | Small-Cap Core | 21,651 | New Holding | 21,651 | 100 % | $97,646 | $83,356 | $-14,290 | -14.63 % | $-14,290 | | | | | | News Article | History of Valic Co I-Small Cap Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Bailard Biehl And Kaiser Inc | Institution | 157,000 | Added More | 7,000 | 4.66 % | $681,380 | $604,450 | $-76,930 | -11.29 % | $-3,430 | | | | | | News Article | History of Bailard Biehl And Kaiser Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -9,020 | -100 % | | | | -17.20 % | $7,216 | | | | | | News Article | History of Blackrock Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii-Fidelity Advisor Biotechnology Fund | Health/Biotech | 9,000 | Added More | 4,500 | 100.00 % | $46,620 | $34,650 | $-11,970 | -25.67 % | $-5,985 | | | | | | News Article | History of Fidelity Advisor Series Vii-Fidelity Advisor Biotechnology Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust-Value Fund | Multi-Cap Value | 63,300 | New Holding | 63,300 | 100 % | $311,436 | $243,705 | $-67,731 | -21.74 % | $-67,731 | | | | | | News Article | History of Usaa Mutual Funds Trust-Value Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc-International Core Equity Portfolio | International Small-Mid-Cap Value | 49,146 | No Change | 0 | 0 % | $267,846 | $189,212 | $-78,634 | -29.35 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc-International Core Equity Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc-International Vector Equity Portfolio | No Data | 18,600 | No Change | 0 | 0 % | $101,370 | $71,610 | $-29,760 | -29.35 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc-International Vector Equity Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc-Us Sustainability Core 1 Portfolio | No Data | 500 | No Change | 0 | 0 % | $2,725 | $1,925 | $-800 | -29.35 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc-Us Sustainability Core 1 Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct-Hartford Global Health Fund | Health/Biotech | 476 | Sold Some | -19 | -3.83 % | $2,594 | $1,833 | $-762 | -29.35 % | $30 | | | | | | News Article | History of Hartford Mutual Funds Incct-Hartford Global Health Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust-Jackson Perspective Index 5 Fund | Specialty & Misc | 303 | No Change | 0 | 0 % | $1,651 | $1,167 | $-485 | -29.35 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust-Jackson Perspective Index 5 Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds-Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -2,750 | -100 % | | | | -31.00 % | $4,758 | | | | | | News Article | History of Massmutual Premier Funds-Massmutual Premier Main Street Small Cap Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds-Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -5,000 | -100 % | | | | -31.00 % | $8,650 | | | | | | News Article | History of Massmutual Premier Funds-Massmutual Premier Small Company Opportunities Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc-International Fund | International Multi-Cap Core | 3,886 | No Change | 0 | 0 % | $21,684 | $14,961 | $-6,723 | -31.00 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc-International Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust-Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 508 | New Holding | 508 | 100 % | $2,835 | $1,956 | $-879 | -31.00 % | $-879 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust-Powershares Dynamic Small Cap Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust-Direxion Daily Small Cap Bull 3x Shares | No Data | | Sold All | -8,275 | -100 % | | | | -30.00 % | $13,654 | | | | | | News Article | History of Direxion Shares Etf Trust-Direxion Daily Small Cap Bull 3x Shares Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust-Rydex Inverse Russell 2000 Etf | Specialty & Misc | 570 | New Holding | 570 | 100 % | $3,141 | $2,195 | $-946 | -30.12 % | $-946 | | | | | | News Article | History of Rydex Etf Trust-Rydex Inverse Russell 2000 Etf Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc-Wilshire Small Company Growth Portfolio | Small-Cap Growth | | Sold All | -50 | -100 % | | | | -27.76 % | $74 | | | | | | News Article | History of Wilshire Mutual Funds Inc-Wilshire Small Company Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds-Banking Fund | Financial Services | 714 | Sold Some | -144 | -16.78 % | $3,791 | $2,749 | $-1,042 | -27.49 % | $210 | | | | | | News Article | History of Rydex Series Funds-Banking Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust-Biotechnology Fund | Health/Biotech | 17,054 | Sold Some | -7,571 | -30.74 % | $90,557 | $65,658 | $-24,899 | -27.49 % | $11,054 | | | | | | News Article | History of Rydex Variable Trust-Biotechnology Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust-Ast Federated Aggressive Growth Portfolio | Multi-Cap Growth | 169,336 | Added More | 29,136 | 20.78 % | $914,414 | $651,944 | $-262,471 | -28.70 % | $-45,161 | | | | | | News Article | History of Advanced Series Trust-Ast Federated Aggressive Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust-Multimanager Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -19,600 | -100 % | | | | -28.70 % | $30,380 | | | | | | News Article | History of Axa Premier Vip Trust-Multimanager Small Cap Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust-Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 45,600 | Added More | 31,000 | 212.32 % | $246,240 | $175,560 | $-70,680 | -28.70 % | $-48,050 | | | | | | News Article | History of Eq Advisors Trust-Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust-Eqalliancebernstein Value Portfolio | Multi-Cap Value | 4,780 | New Holding | 4,780 | 100 % | $25,812 | $18,403 | $-7,409 | -28.70 % | $-7,409 | | | | | | News Article | History of Eq Advisors Trust-Eqalliancebernstein Value Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust-Eqbond Index Portfolio | Specialty & Misc | 71,079 | Added More | 7,160 | 11.20 % | $383,827 | $273,654 | $-110,172 | -28.70 % | $-11,098 | | | | | | News Article | History of Eq Advisors Trust-Eqbond Index Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Hartford Series Fund Inc-Hartford Global Health Hls Fund | Health/Biotech | 244 | New Holding | 244 | 100 % | $1,318 | $939 | $-378 | -28.70 % | $-378 | | | | | | News Article | History of Hartford Series Fund Inc-Hartford Global Health Hls Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I-Jpmorgan Japan Fund | Japanese | | Sold All | -4 | -100 % | | | | -28.70 % | $6 | | | | | | News Article | History of Jpmorgan Trust I-Jpmorgan Japan Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I-Jpmorgan Small Cap Core Fund | Small-Cap Core | | Sold All | -28 | -100 % | | | | -28.70 % | $43 | | | | | | News Article | History of Jpmorgan Trust I-Jpmorgan Small Cap Core Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Un Capital Advisers Trust-Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 4,690 | Sold Some | -1,910 | -28.93 % | $25,326 | $18,057 | $-7,270 | -28.70 % | $2,961 | | | | | | News Article | History of Un Capital Advisers Trust-Sc Oppenheimer Main Street Small Cap Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii-Mml Small Cap Equity Fund | Small-Cap Core | 4,000 | Added More | 320 | 8.69 % | $21,080 | $15,400 | $-5,680 | -26.94 % | $-454 | | | | | | News Article | History of Mml Series Investment Fund Ii-Mml Small Cap Equity Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund-Pd Small-Cap Growth Index Portfolio | No Data | 330 | No Compare | | | $1,739 | $1,271 | $-469 | -26.94 % | | | | | | | News Article | History of Pacific Select Fund-Pd Small-Cap Growth Index Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund-Pd Small-Cap Value Index Portfolio | No Data | 134 | No Compare | | | $706 | $516 | $-190 | -26.94 % | | | | | | | News Article | History of Pacific Select Fund-Pd Small-Cap Value Index Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund-Small-Cap Index Portfolio | No Data | 14,802 | New Holding | 14,802 | 100 % | $78,007 | $56,988 | $-21,019 | -26.94 % | $-21,019 | | | | | | News Article | History of Pacific Select Fund-Small-Cap Index Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Treettracks Series Trust-Spdr Dividend Etf | Specialty & Misc | | Sold All | -4,534 | -100 % | | | | -26.94 % | $6,438 | | | | | | News Article | History of Treettracks Series Trust-Spdr Dividend Etf Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds-Biotechnology Fund | Health/Biotech | 109,589 | Added More | 30,803 | 39.09 % | $573,150 | $421,918 | $-151,233 | -26.38 % | $-42,508 | | | | | | News Article | History of Rydex Series Funds-Biotechnology Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust-Biondo Fund | Health/Biotech | | Sold All | -520 | -100 % | | | | -26.94 % | $738 | | | | | | News Article | History of Northern Lights Fund Trust-Biondo Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund-Stock Index Fund | Specialty & Misc | 300 | No Change | 0 | 0 % | $1,581 | $1,155 | $-426 | -26.94 % | $0 | | | | | | News Article | History of Tiaa Cref Life Fund-Stock Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust-Value Fund | Multi-Cap Value | | Sold All | -63,300 | -100 % | | | | -26.94 % | $89,886 | | | | | | News Article | History of Usaa Mutual Funds Trust-Value Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 303,079 | Sold Some | -14,632 | -4.60 % | $1,618,442 | $1,166,854 | $-451,588 | -27.90 % | $21,802 | | | | | | News Article | History of Ishares Trust-Ishares Nasdaq Biotechnology Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 144,875 | Sold Some | -35,633 | -19.74 % | $773,633 | $557,769 | $-215,864 | -27.90 % | $53,093 | | | | | | News Article | History of Ishares Trust-Ishares Russell 2000 Growth Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 2000 Index Fund | Specialty & Misc | 321,777 | Sold Some | -7,472 | -2.26 % | $1,718,289 | $1,238,841 | $-479,448 | -27.90 % | $11,133 | | | | | | News Article | History of Ishares Trust-Ishares Russell 2000 Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 2000 Value Index Fund | Multi-Cap Value | 54,258 | New Holding | 54,258 | 100 % | $289,738 | $208,893 | $-80,844 | -27.90 % | $-80,844 | | | | | | News Article | History of Ishares Trust-Ishares Russell 2000 Value Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 1,567 | Sold Some | -168 | -9.68 % | $8,368 | $6,033 | $-2,335 | -27.90 % | $250 | | | | | | News Article | History of Ishares Trust-Ishares Russell 3000 Growth Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 3000 Index Fund | Specialty & Misc | 6,999 | Added More | 420 | 6.38 % | $37,375 | $26,946 | $-10,429 | -27.90 % | $-626 | | | | | | News Article | History of Ishares Trust-Ishares Russell 3000 Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell 3000 Value Index Fund | Multi-Cap Value | 435 | New Holding | 435 | 100 % | $2,323 | $1,675 | $-648 | -27.90 % | $-648 | | | | | | News Article | History of Ishares Trust-Ishares Russell 3000 Value Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust-Ishares Russell Microcap Index Fund | Specialty & Misc | 42,931 | Added More | 12,164 | 39.53 % | $229,252 | $165,284 | $-63,967 | -27.90 % | $-18,124 | | | | | | News Article | History of Ishares Trust-Ishares Russell Microcap Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ti Classic Funds-Small Cap Growth Stock Fund | Small-Cap Growth | | Sold All | -201,634 | -100 % | | | | -27.90 % | $300,435 | | | | | | News Article | History of Ti Classic Funds-Small Cap Growth Stock Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds-Equity Index Fund | Specialty & Misc | 18,036 | Added More | 11,401 | 171.83 % | $100,100 | $69,439 | $-30,661 | -30.63 % | $-19,382 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds-Equity Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds-Growth Equity Fund | Multi-Cap Growth | | Sold All | -9,465 | -100 % | | | | -30.63 % | $16,091 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds-Growth Equity Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Extended Market Index Fund | Mid-Cap Core | 134,902 | New Holding | 134,902 | 100 % | $748,706 | $519,373 | $-229,333 | -30.63 % | $-229,333 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Extended Market Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Growth Index Fund | Large-Cap Growth | 234,149 | New Holding | 234,149 | 100 % | $1,299,527 | $901,474 | $-398,053 | -30.63 % | $-398,053 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Growth Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds-Vanguard Total Stock Market Index Fund | Multi-Cap Core | 304,981 | New Holding | 304,981 | 100 % | $1,692,645 | $1,174,177 | $-518,468 | -30.63 % | $-518,468 | | | | | | News Article | History of Vanguard Index Funds-Vanguard Total Stock Market Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds-Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 8,236 | No Change | 0 | 0 % | $45,710 | $31,709 | $-14,001 | -30.63 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds-Vanguard Balanced Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds-Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 17,436 | Added More | 9,200 | 111.70 % | $96,770 | $67,129 | $-29,641 | -30.63 % | $-15,640 | | | | | | News Article | History of Vanguard Balanced Index Funds-Vanguard Balanced Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc-Maxim Small-Cap Growth Portfolio | No Data | | Sold All | -40,100 | -100 % | | | | -29.09 % | $63,358 | | | | | | News Article | History of Maxim Series Fund Inc-Maxim Small-Cap Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds-Oppenheimer Main Street Fundva | Specialty & Misc | 23,189 | New Holding | 23,189 | 100 % | $123,829 | $89,278 | $-34,552 | -27.90 % | $-34,552 | | | | | | News Article | History of Oppenheimer Variable Account Funds-Oppenheimer Main Street Fundva Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-21 | 2009-06-30 | N-CSR | Oppenheimer Main Street Small Cap Fund-Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 98,990 | New Holding | 98,990 | 100 % | $544,445 | $381,112 | $-163,334 | -30.00 % | $-163,334 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund-Oppenheimer Main Street Small Cap Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-18 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 1,762,064 | Added More | 194,100 | 12.37 % | $9,286,077 | $6,783,946 | $-2,502,131 | -26.94 % | $-275,622 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-18 | 2009-06-30 | 13F-HR | Us Bancorp De | Institution | 180 | No Change | 0 | 0 % | $949 | $693 | $-256 | -26.94 % | $0 | | | | | | News Article | History of Us Bancorp De Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Madison Square Investors Llc | No Data | 1,943 | Sold Some | -262 | -11.88 % | $10,337 | $7,481 | $-2,856 | -27.63 % | $385 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Morgan Stanley | Institution | 2,128,256 | Added More | 458,815 | 27.48 % | $11,322,322 | $8,193,786 | $-3,128,536 | -27.63 % | $-674,458 | | | | | | News Article | History of Morgan Stanley Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Tudor Investment Corp Et Al | Institution | 2,342,388 | No Change | 0 | 0 % | $12,461,504 | $9,018,194 | $-3,443,310 | -27.63 % | $0 | | | | | | News Article | History of Tudor Investment Corp Et Al Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | American International Group Inc | Institution | 21,651 | Added More | 1 | 0.00 % | $115,400 | $83,356 | $-32,043 | -27.76 % | $-1 | | | | | | News Article | History of American International Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Axa | Institution | 159,859 | Added More | 20,160 | 14.43 % | $852,048 | $615,457 | $-236,591 | -27.76 % | $-29,837 | | | | | | News Article | History of Axa Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Black River Asset Management Llc | Institution | | Sold All | -3,138 | -100 % | | | | -27.76 % | $4,644 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Citadel L P | Institution | 10,276 | Added More | 6,849 | 199.85 % | $54,771 | $39,563 | $-15,208 | -27.76 % | $-10,137 | | | | | | News Article | History of Citadel L P Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Citigroup Inc | Institution | 51,945 | Added More | 20,591 | 65.67 % | $276,867 | $199,988 | $-76,879 | -27.76 % | $-30,475 | | | | | | News Article | History of Citigroup Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Credit Agricole S A | Institution | 350 | No Change | 0 | 0 % | $1,866 | $1,348 | $-518 | -27.76 % | $0 | | | | | | News Article | History of Credit Agricole S A Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 76,200 | New Holding | 76,200 | 100 % | $406,146 | $293,370 | $-112,776 | -27.76 % | $-112,776 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Ei Trust Co | Institution | 7,121 | Added More | 3,820 | 115.72 % | $37,955 | $27,416 | $-10,539 | -27.76 % | $-5,654 | | | | | | News Article | History of Ei Trust Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Falcon Investment Management Llc | Institution | 58,400 | New Holding | 58,400 | 100 % | $311,272 | $224,840 | $-86,432 | -27.76 % | $-86,432 | | | | | | News Article | History of Falcon Investment Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Fifth Third Bancorp | Institution | 810 | No Change | 0 | 0 % | $4,317 | $3,119 | $-1,199 | -27.76 % | $0 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Fmr Corp | Institution | 106,900 | No Change | 0 | 0 % | $569,777 | $411,565 | $-158,212 | -27.76 % | $0 | | | | | | News Article | History of Fmr Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Geode Capital Management Llc | Institution | 82,572 | Added More | 28,164 | 51.76 % | $440,109 | $317,902 | $-122,207 | -27.76 % | $-41,683 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 721,536 | Added More | 227,251 | 45.97 % | $3,845,787 | $2,777,914 | $-1,067,873 | -27.76 % | $-336,331 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Grt Capital Partners Llc | Institution | 37,580 | Added More | 11,810 | 45.82 % | $200,301 | $144,683 | $-55,618 | -27.76 % | $-17,479 | | | | | | News Article | History of Grt Capital Partners Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Haw D E And Co Inc | Institution | 148,591 | Added More | 93,549 | 169.95 % | $791,990 | $572,075 | $-219,915 | -27.76 % | $-138,453 | | | | | | News Article | History of Haw D E And Co Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Ing Groep Nv | Institution | 11,450 | New Holding | 11,450 | 100 % | $61,029 | $44,083 | $-16,946 | -27.76 % | $-16,946 | | | | | | News Article | History of Ing Groep Nv Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | 133,500 | New Holding | 133,500 | 100 % | $711,555 | $513,975 | $-197,580 | -27.76 % | $-197,580 | | | | | | News Article | History of Jacobs Levy Equity Management Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Kbc Group Nv | Institution | 14,415 | Sold Some | -8,212 | -36.29 % | $76,832 | $55,498 | $-21,334 | -27.76 % | $12,154 | | | | | | News Article | History of Kbc Group Nv Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Martingale Asset Management L P | Institution | 46,700 | Added More | 4,500 | 10.66 % | $248,911 | $179,795 | $-69,116 | -27.76 % | $-6,660 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 4,550 | New Holding | 4,550 | 100 % | $24,252 | $17,518 | $-6,734 | -27.76 % | $-6,734 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Millennium Management Llc | Institution | 71,563 | New Holding | 71,563 | 100 % | $381,431 | $275,518 | $-105,913 | -27.76 % | $-105,913 | | | | | | News Article | History of Millennium Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 148,400 | Added More | 38,400 | 34.90 % | $790,972 | $571,340 | $-219,632 | -27.76 % | $-56,832 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Northern Trust Corp | Institution | 314,375 | Added More | 66,226 | 26.68 % | $1,675,619 | $1,210,344 | $-465,275 | -27.76 % | $-98,014 | | | | | | News Article | History of Northern Trust Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Oppenheimer Funds Inc | Institution | 369,279 | Sold Some | -22,704 | -5.79 % | $1,968,257 | $1,421,724 | $-546,533 | -27.76 % | $33,602 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 17,800 | Added More | 5,200 | 41.26 % | $94,874 | $68,530 | $-26,344 | -27.76 % | $-7,696 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Principal Financial Group Inc | Institution | 361,673 | Sold Some | -150 | -0.04 % | $1,927,717 | $1,392,441 | $-535,276 | -27.76 % | $222 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | | Sold All | -1,795 | -100 % | | | | -27.76 % | $2,657 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 300 | Sold Some | -23,800 | -98.75 % | $1,599 | $1,155 | $-444 | -27.76 % | $35,224 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Toronto Dominion Bank | Institution | 11,576 | New Holding | 11,576 | 100 % | $61,700 | $44,568 | $-17,132 | -27.76 % | $-17,132 | | | | | | News Article | History of Toronto Dominion Bank Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Two Sigma Investments Llc | Institution | 25,400 | New Holding | 25,400 | 100 % | $135,382 | $97,790 | $-37,592 | -27.76 % | $-37,592 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Vanguard Group Inc | Institution | 1,134,400 | Added More | 138,103 | 13.86 % | $6,046,352 | $4,367,440 | $-1,678,912 | -27.76 % | $-204,392 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Wellington Management Co Llp | Institution | 2,023,326 | Sold Some | -1,487,648 | -42.37 % | $10,784,328 | $7,789,805 | $-2,994,522 | -27.76 % | $2,201,719 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-14 | 2009-06-30 | 13F-HR | Zebra Capital Management Llc | Institution | | Sold All | -6,123 | -100 % | | | | -27.76 % | $9,062 | | | | | | News Article | History of Zebra Capital Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Ameriprise Financial Inc | Institution | 12,800 | Added More | 2,827 | 28.34 % | $70,784 | $49,280 | $-21,504 | -30.37 % | $-4,749 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 202,649 | Sold Some | -75,680 | -27.19 % | $1,120,649 | $780,199 | $-340,450 | -30.37 % | $127,142 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Barclays Plc | Institution | 78,394 | Added More | 62,676 | 398.75 % | $433,519 | $301,817 | $-131,702 | -30.37 % | $-105,296 | | | | | | News Article | History of Barclays Plc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Federated Investors Inc | Institution | 4,591,212 | Added More | 96,077 | 2.13 % | $25,389,402 | $17,676,166 | $-7,713,236 | -30.37 % | $-161,409 | | | | | | News Article | History of Federated Investors Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 40,728 | Sold Some | -1,493 | -3.53 % | $225,226 | $156,803 | $-68,423 | -30.37 % | $2,508 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Ing Investment Management Co | Institution | 11,450 | Added More | 5,400 | 89.25 % | $63,319 | $44,083 | $-19,236 | -30.37 % | $-9,072 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | J P Morgan Chase And Co | Institution | 57,741 | Sold Some | -7,371 | -11.32 % | $319,308 | $222,303 | $-97,005 | -30.37 % | $12,383 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Renaissance Technologies Corp | Institution | 113,803 | New Holding | 113,803 | 100 % | $629,331 | $438,142 | $-191,189 | -30.37 % | $-191,189 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Ubs Ag | Institution | 1,000 | New Holding | 1,000 | 100 % | $5,530 | $3,850 | $-1,680 | -30.37 % | $-1,680 | | | | | | News Article | History of Ubs Ag Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Untrust Banks Inc | Institution | | Sold All | -257,315 | -100 % | | | | -30.37 % | $432,289 | | | | | | News Article | History of Untrust Banks Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-13 | 2009-06-30 | 13F-HR | Wells Fargo And Co | Institution | 10,845 | Added More | 10,745 | 10745.00 % | $59,973 | $41,753 | $-18,220 | -30.37 % | $-18,052 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Credit Suisse First Boston | Institution | 29,192 | New Holding | 29,192 | 100 % | $166,978 | $112,389 | $-54,589 | -32.69 % | $-54,589 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Ig Investment Management Ltd | Institution | 128,272 | Added More | 5,200 | 4.22 % | $733,716 | $493,847 | $-239,869 | -32.69 % | $-9,724 | | | | | | News Article | History of Ig Investment Management Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Knott David M | Institution | 513,961 | Sold Some | -40,000 | -7.22 % | $2,939,857 | $1,978,750 | $-961,107 | -32.69 % | $74,800 | | | | | | News Article | History of Knott David M Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Usquehanna International Group Llp | Institution | 33,773 | New Holding | 33,773 | 100 % | $193,182 | $130,026 | $-63,156 | -32.69 % | $-63,156 | | | | | | News Article | History of Usquehanna International Group Llp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-12 | 2009-06-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 75,900 | No Change | 0 | 0 % | $434,148 | $292,215 | $-141,933 | -32.69 % | $0 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Amvescap Plc | Institution | 254 | Sold Some | -254 | -50.00 % | $1,379 | $978 | $-401 | -29.09 % | $401 | | | | | | News Article | History of Amvescap Plc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Blackrock Inc | No Data | 9,020 | New Holding | 9,020 | 100 % | $48,979 | $34,727 | $-14,252 | -29.09 % | $-14,252 | | | | | | News Article | History of Blackrock Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Ectoral Asset Management Inc | Institution | 3,804,278 | Sold Some | -420,011 | -9.94 % | $20,657,230 | $14,646,470 | $-6,010,759 | -29.09 % | $663,617 | | | | | | News Article | History of Ectoral Asset Management Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Glenmede Trust Co Na | Institution | 22,107 | Sold Some | -2,813 | -11.28 % | $120,041 | $85,112 | $-34,929 | -29.09 % | $4,445 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 17,584 | Sold Some | -7,611 | -30.20 % | $95,481 | $67,698 | $-27,783 | -29.09 % | $12,025 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Padco Advisors Inc | Institution | 110,303 | Added More | 30,211 | 37.72 % | $598,945 | $424,667 | $-174,279 | -29.09 % | $-47,733 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-11 | 2009-06-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | | Sold All | -83,000 | -100 % | | | | -29.09 % | $131,140 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 657,007 | Sold Some | -4,133 | -0.62 % | $3,495,277 | $2,529,477 | $-965,800 | -27.63 % | $6,076 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 27,310 | Sold Some | -1,993 | -6.80 % | $145,289 | $105,144 | $-40,146 | -27.63 % | $2,930 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Technical Financial Services Llc | Institution | | Sold All | -72,534 | -100 % | | | | -27.63 % | $106,625 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Progenics Pharmaceuticals Inc |
RSS feed for PGNX